Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

argenx SE

ARGXNASDAQ
Healthcare
Biotechnology
$847.26
$0.00(0.00%)
U.S. Market is Open • 14:06

argenx SE Fundamental Analysis

argenx SE (ARGX) shows strong financial fundamentals with a PE ratio of 37.72, profit margin of 37.50%, and ROE of 23.66%. The company generates $3.7B in annual revenue with strong year-over-year growth of 77.27%.

Key Strengths

ROE23.66%
PEG Ratio0.93
Current Ratio5.60

Areas of Concern

No major concerns flagged.
We analyze ARGX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 96.6/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
96.6/100

We analyze ARGX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

ARGX demonstrates superior asset utilization.

ROA > 10%
19.12%

Valuation Score

Moderate

ARGX shows balanced valuation metrics.

PE < 25
37.72
PEG Ratio < 2
0.93

Growth Score

Moderate

ARGX shows steady but slowing expansion.

Revenue Growth > 5%
77.27%
EPS Growth > 10%
3.70%

Financial Health Score

Excellent

ARGX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
5.60

Profitability Score

Excellent

ARGX achieves industry-leading margins.

ROE > 15%
23.66%
Net Margin ≥ 15%
37.50%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ARGX Expensive or Cheap?

P/E Ratio

ARGX trades at 37.72 times earnings. This suggests a premium valuation.

37.72

PEG Ratio

When adjusting for growth, ARGX's PEG of 0.93 indicates potential undervaluation.

0.93

Price to Book

The market values argenx SE at 8.49 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.49

EV/EBITDA

Enterprise value stands at 58.43 times EBITDA. This signals the market has high growth expectations.

58.43

How Well Does ARGX Make Money?

Net Profit Margin

For every $100 in sales, argenx SE keeps $37.50 as profit after all expenses.

37.50%

Operating Margin

Core operations generate 12.89 in profit for every $100 in revenue, before interest and taxes.

12.89%

ROE

Management delivers $23.66 in profit for every $100 of shareholder equity.

23.66%

ROA

argenx SE generates $19.12 in profit for every $100 in assets, demonstrating efficient asset deployment.

19.12%

Following the Money - Real Cash Generation

Operating Cash Flow

argenx SE produces operating cash flow of $486.44M, showing steady but balanced cash generation.

$486.44M

Free Cash Flow

argenx SE generates strong free cash flow of $480.11M, providing ample flexibility for dividends, buybacks, or growth.

$480.11M

FCF Per Share

Each share generates $7.76 in free cash annually.

$7.76

FCF Yield

ARGX converts 0.90% of its market value into free cash.

0.90%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

37.72

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.93

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.49

vs 25 benchmark

P/S Ratio

Price to sales ratio

14.34

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.007

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.60

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.24

vs 25 benchmark

ROA

Return on assets percentage

0.19

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How ARGX Stacks Against Its Sector Peers

MetricARGX ValueSector AveragePerformance
P/E Ratio37.7229.43 Worse (Expensive)
ROE23.66%800.00% Weak
Net Margin37.50%-20145.00% (disorted) Strong
Debt/Equity0.010.30 Strong (Low Leverage)
Current Ratio5.604.64 Strong Liquidity
ROA19.12%-17936.00% (disorted) Strong

ARGX outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews argenx SE's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

1541.52%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

362.92%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-132.33%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ